A detailed history of Kinsale Capital Group, Inc. transactions in Mckesson Corp stock. As of the latest transaction made, Kinsale Capital Group, Inc. holds 15,993 shares of MCK stock, worth $13.5 Million. This represents 2.26% of its overall portfolio holdings.

Number of Shares
15,993
Previous 14,874 7.52%
Holding current value
$13.5 Million
Previous $10.9 Million 13.36%
% of portfolio
2.26%
Previous 2.25%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025

BUY
$659.01 - $772.54 $737,432 - $864,472
1,119 Added 7.52%
15,993 $12.4 Million
Q2 2025

Aug 06, 2025

BUY
$652.83 - $732.78 $676,331 - $759,160
1,036 Added 7.49%
14,874 $10.9 Million
Q1 2025

May 07, 2025

BUY
$566.21 - $672.99 $997,662 - $1.19 Million
1,762 Added 14.59%
13,838 $9.31 Million
Q4 2024

Feb 05, 2025

BUY
$482.27 - $628.5 $655,404 - $854,131
1,359 Added 12.68%
12,076 $6.88 Million
Q3 2024

Nov 06, 2024

BUY
$479.06 - $630.38 $674,037 - $886,944
1,407 Added 15.11%
10,717 $5.3 Million
Q2 2024

Aug 07, 2024

BUY
$518.81 - $607.81 $693,130 - $812,034
1,336 Added 16.75%
9,310 $5.44 Million
Q1 2024

May 01, 2024

BUY
$473.42 - $539.26 $723,859 - $824,528
1,529 Added 23.72%
7,974 $4.28 Million
Q4 2023

Feb 07, 2024

BUY
$437.42 - $470.64 $581,768 - $625,951
1,330 Added 26.0%
6,445 $2.98 Million
Q3 2023

Nov 01, 2023

BUY
$402.4 - $446.42 $432,580 - $479,901
1,075 Added 26.61%
5,115 $2.22 Million
Q2 2023

Aug 02, 2023

BUY
$354.01 - $427.31 $491,365 - $593,106
1,388 Added 52.34%
4,040 $1.73 Million
Q1 2023

May 04, 2023

BUY
$335.35 - $386.06 $538,907 - $620,398
1,607 Added 153.78%
2,652 $944,000
Q4 2022

Feb 10, 2023

BUY
$346.68 - $397.58 $362,280 - $415,471
1,045 New
1,045 $392,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $121B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Kinsale Capital Group, Inc. Portfolio

Follow Kinsale Capital Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kinsale Capital Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kinsale Capital Group, Inc. with notifications on news.